Cargando…
Emerging Pharmacological Treatments for Migraine in the Pediatric Population
Headaches in children and adolescents have high incidence and prevalence rates, with consequent elevated disability costs to individuals and the community. Pediatric migraine is a disorder with substantial clinical differences compared to the adult form. Few clinical trials have been performed speci...
Autores principales: | Iannone, Luigi Francesco, De Cesaris, Francesco, Geppetti, Pierangelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031827/ https://www.ncbi.nlm.nih.gov/pubmed/35455026 http://dx.doi.org/10.3390/life12040536 |
Ejemplares similares
-
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report
por: Iannone, Luigi Francesco, et al.
Publicado: (2021) -
Migraine Treatment: Towards New Pharmacological Targets
por: Silvestro, Marcello, et al.
Publicado: (2023) -
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
por: Iannone, Luigi Francesco, et al.
Publicado: (2022) -
CGRP receptors and TRP channels in migraine
por: Geppetti, Pierangelo, et al.
Publicado: (2015) -
P010. OnabotulinumtoxinA for treatment of chronic migraine: results after 1 year of treatment
por: Rossi, Eleonora, et al.
Publicado: (2015)